Literature DB >> 17768422

Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens.

B Furusato1, S Shaheduzzaman, G Petrovics, A Dobi, M Seifert, L Ravindranath, M E Nau, T Werner, M Vahey, D G McLeod, S Srivastava, I A Sesterhenn.   

Abstract

Formalin-fixed paraffin-embedded (FFPE) prostate specimens are rich sources of molecular pathological information. However, FFPE-based microarray analysis of tissue samples may be hampered by the degradation and chemical alteration of RNA molecules due to the preservation procedure. In this report, we employed a probe analyses of Affymetrix oligonucleotide arrays at individual probe level to compensate for the potential loss of gene identifications associated with compromised mRNA quality in FFPE preparations. Furthermore, to increase the sample quality, we utilized laser capture microdissection of prostate tumor and benign epithelial cells. Remarkably, combination of these approaches recapitulated the common prostate cancer-associated gene expression alteration. Identification of prostate cancer associated-gene expression alterations such as AMACR, Kallikrein gene family and genes associated with androgen signaling such as PDEF and STEAP were consistent with previous findings reported in prostate cancer. These data suggest that combination of laser capture dissection with computational enhancement of microarray data may be useful for the assessment of gene expression changes in FFPE prostate cancer specimens.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17768422     DOI: 10.1038/sj.pcan.4501007

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  11 in total

1.  Quantitative expression profiling in formalin-fixed paraffin-embedded samples by affymetrix microarrays.

Authors:  Diana Abdueva; Michele Wing; Betty Schaub; Timothy Triche; Elai Davicioni
Journal:  J Mol Diagn       Date:  2010-06-03       Impact factor: 5.568

2.  Predictive and prognostic molecular markers for cancer medicine.

Authors:  Sunali Mehta; Andrew Shelling; Anita Muthukaruppan; Annette Lasham; Cherie Blenkiron; George Laking; Cristin Print
Journal:  Ther Adv Med Oncol       Date:  2010-03       Impact factor: 8.168

3.  Development of a microarray platform for FFPET profiling: application to the classification of human tumors.

Authors:  Sven Duenwald; Mingjie Zhou; Yanqun Wang; Serguei Lejnine; Amit Kulkarni; Jaime Graves; Ryan Smith; John Castle; George Tokiwa; Bernard Fine; Hongyue Dai; Thomas Fare; Matthew Marton
Journal:  J Transl Med       Date:  2009-07-28       Impact factor: 5.531

4.  Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.

Authors:  Jennifer L Gregg; Kathleen E Brown; Eric M Mintz; Helen Piontkivska; Gail C Fraizer
Journal:  BMC Cancer       Date:  2010-04-28       Impact factor: 4.430

5.  Expression analysis of Barrett's esophagus-associated high-grade dysplasia in laser capture microdissected archival tissue.

Authors:  Edmond Sabo; Patricia A Meitner; Rosemarie Tavares; Christopher L Corless; Gregory Y Lauwers; Steven F Moss; Murray B Resnick
Journal:  Clin Cancer Res       Date:  2008-10-15       Impact factor: 12.531

6.  Prostate cancer gene expression signature of patients with high body mass index.

Authors:  S Sharad; A Srivastava; S Ravulapalli; P Parker; Y Chen; H Li; G Petrovics; A Dobi
Journal:  Prostate Cancer Prostatic Dis       Date:  2010-11-09       Impact factor: 5.554

7.  Oncogenic activation of ERG: A predominant mechanism in prostate cancer.

Authors:  Taduru L Sreenath; Albert Dobi; Gyorgy Petrovics; Shiv Srivastava
Journal:  J Carcinog       Date:  2011-12-31

8.  Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer.

Authors:  Svitlana Tyekucheva; Michaela Bowden; Clyde Bango; Francesca Giunchi; Ying Huang; Chensheng Zhou; Arrigo Bondi; Rosina Lis; Mieke Van Hemelrijck; Ove Andrén; Sven-Olof Andersson; R William Watson; Stephen Pennington; Stephen P Finn; Neil E Martin; Meir J Stampfer; Giovanni Parmigiani; Kathryn L Penney; Michelangelo Fiorentino; Lorelei A Mucci; Massimo Loda
Journal:  Nat Commun       Date:  2017-09-04       Impact factor: 14.919

Review 9.  The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review.

Authors:  Naveen Kachroo; Vincent J Gnanapragasam
Journal:  J Cancer Res Clin Oncol       Date:  2012-11-28       Impact factor: 4.553

10.  Long-term RNA persistence in postmortem contexts.

Authors:  Sarah L Fordyce; Marie-Louise Kampmann; Nienke L van Doorn; M Thomas P Gilbert
Journal:  Investig Genet       Date:  2013-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.